There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor.

There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor.
复制标题

DOI:
10.1016/j.steroids.2016.05.003
复制
发表时间:
2016-10
期刊:
影响因子:
2.7
通讯作者:
Uhlenhaut NH
Uhlenhaut NH
中科院分区:
医学3区
文献类型:
--
作者:
Greulich F;Hemmer MC;Rollins DA;Rogatsky I;Uhlenhaut NH

文献摘要

参考文献

被引文献

相似文献

糖皮质激素(Glucocorticoid,GC)作为糖皮质激素受体(glucocorticoid receptor,GR)的配体,代表了用于抗炎和免疫抑制治疗的最有效和最常用的药物类别之一。此外,它在生理和病理生理过程中的作用使GR成为重要的研究目标。在过去的几十年里,人们对GC的生理和药理作用有了大量的了解。当今的下一代测序技术时代正在开始阐明GR细胞类型特异性作用背后的分子和基因组回路。这篇综述主要集中在最近的研究中获得的概念和见解,在两个最重要的组织GC行动:肝脏(介导GR的代谢作用)和巨噬细胞(作为抗炎GC治疗的主要目标)。我们总结了从转基因小鼠模型,分子和全基因组研究中获得的结果,以说明GR与DNA,染色质,辅助调节因子和其他转录因子的复杂相互作用。表征围绕GR组装的细胞类型特异性转录复合物将为未来开发新的抗炎和代谢疗法铺平道路。
Glucocorticoids (GCs), as ligands for the glucocorticoid receptor (GR), represent one of the most effective and frequently used classes of drugs for anti-inflammatory and immunosuppressive therapy. In addition, its role in physiological and pathophysiological processes makes the GR an important research target. The past decades have yielded a wealth of insight into the physiological and pharmacological effects of GCs. Today’s era of next generation sequencing techniques is now beginning to elucidate the molecular and genomic circuits underlying GR’s cell type-specific actions. This review focuses on the concepts and insights gained from recent studies in two of the most important tissues for GC action: the liver (mediating GR’s metabolic effects) and macrophages (as the main target of anti-inflammatory GC therapy). We summarize results obtained from transgenic mouse models, molecular and genome-wide studies to illustrate GR’s complex interactions with DNA, chromatin, co-regulators and other transcription factors. Characterizing the cell type-specific transcriptional complexes assembled around GR will pave the road for the development of new anti-inflammatory and metabolic therapies in the future.
DOI: 10.1371/journal.pone.0015419
发表时间: 2010-11-03
期刊: PloS one
影响因子: 3.7
作者:
Akagi T;Thoennissen NH;George A;Crooks G;Song JH;Okamoto R;Nowak D;Gombart AF;Koeffler HP
通讯作者: Koeffler HP
DOI: 10.1371/journal.pone.0097549
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Diefenbacher ME;Reich D;Dahley O;Kemler D;Litfin M;Herrlich P;Kassel O
通讯作者: Kassel O
糖皮质激素受体在巨噬细胞中协调转录因子主导的调节网络。
DOI: 10.1186/1471-2164-15-656
发表时间: 2014-08-06
期刊: BMC genomics
影响因子: 4.4
作者:
Chinenov Y;Coppo M;Gupte R;Sacta MA;Rogatsky I
通讯作者: Rogatsky I
DOI: 10.1146/annurev-med-051812-145316
发表时间: 2014
影响因子: 10.5
作者:
Dasgupta S;Lonard DM;O'Malley BW
通讯作者: O'Malley BW
DOI: 10.1128/mcb.21.4.1393-1403.2001
发表时间: 2001-02-01
影响因子: 5.3
作者:
Hayhurst, GP;Lee, YH;Gonzalez, FJ
通讯作者: Gonzalez, FJ